The plasma concentration of cholesterol carried in low density lipoproteins is principally determined by the level of LDL receptor activity (P) and the LDL-cholesterol production rate (Jt) found in animals or man. This study delineates which saturated fatty acids alter JU and Jt and so increase the plasma LDL-cholesterol level. J' and Jt were measured in vivo in hamsters fed a constant level of added dietary cholesterol (0.12%) and triacylglycerol (10%), where the triacylglycerol contained only a single saturated fatty acid varying in chain length from 6 to 18 carbon atoms. After feeding for 30 d, the 12:0, 14:0, 16:0, and 18:0 fatty acids, but not the 6:0, 8:0, and 10:0 compounds, became significantly enriched in the liver total lipid fraction of the respective groups fed these fatty acids. However, only the 12:0, 14:0, and 16:0 fatty acids, but not the 6:0, 8:0, 10:0, and 18:0 compounds, suppressed J, increased Jt, and essentially doubled plasma LDL-cholesterol concentrations. Neither the 16:0 nor 18:0 compound altered rates of cholesterol synthesis in the extrahepatic organs, and both lowered the hepatic total cholesterol pool. Thus, the different effects of the 16:0 and 18:0 fatty acids could not be attributed to a difference in cholesterol delivery to the liver. Since these changes in LDL kinetics took place without an apparent alteration in external sterol balance, the regulatory effects of the 12:0, 14:0, and 16:0 fatty acids presumably are mediated through some change in a putative intrahepatic regulatory pool of sterol in the liver. (J.
Introduction
In either the experimental animal or man, the steady-state concentration of cholesterol carried in low density lipoproteins is usually low when the dietary intake of cholesterol and triacylglycerol is minimal (1) (2) (3) (4) (5) ( unpublished observations in cynomolgus monkey). In this situation where little lipid is reaching the liver in the chylomicron remnant, the rate at which LDL cholesterol is being produced and enters the plasma space is low, relative to the rate at which LDL can be removed from the plasma by receptor-dependent transport. In the hamster, for dependent removal (Jm) equals -700 ,gg/h (6, 7) . Similar relative rates for J, and Jm are found in the rat (-100 vs 600 ,gg/h) and rabbit (-700 vs 2 ,100 ,ug/h) fed low-fat diets (6, 8, 9) .
When increasing amounts ofcholesterol alone are added to the diet, there is a dose-dependent increase in the level of cholesteryl esters in the liver, progressive suppression of LDL receptor activity, and small increases in the LDL-cholesterol production rate (7, 10) . As a result of these changes, there are modest increases in the steady-state concentration of LDL-cholesterol in the plasma (10) .
The addition of triacylglycerol to such cholesterol-containing diets often has more dramatic effects on the plasma cholesterol level and the parameters of LDL metabolism that determine these levels. Generally, triacylglycerol containing saturated fatty acids lowers the concentration ofhepatic cholesteryl esters, further suppresses receptor activity, significantly increases the LDL-cholesterol production rate, and, as a consequence of these events, markedly raises the plasma LDL-cholesterol level (10) (11) (12) . In contrast, triacylglycerol that contains predominantly unsaturated fatty acids often elevates the hepatic stores of sterol esters and restores receptor-dependent transport, but has little effect on LDL-cholesterol production rates (10, 12) . The net effect of these changes is usually a smallto-modest decrease in the plasma LDL-cholesterol level (12) . These regulatory properties of saturated and unsaturated fatty acids are dose dependent and algebraically additive, i.e., mixtures ofthese different lipids result in intermediate and predictable alterations in Jm, Jt, and the plasma cholesterol concentration (12) . However, it is also apparent that not all saturated and unsaturated fatty acids produce similar results. For example, feeding hydrogenated coconut oil, which is rich in the 12:0 and 14:0 saturated fatty acids, markedly alters Jm, J., and the plasma cholesterol concentration, while medium chain triglyceride oil, which contains predominantly the 8:0 and 10:0 saturated fatty acids, has virtually no effect on these parameters (7) . Similarly, there is evidence suggesting that different unsaturated fatty acids have quantitatively different effects on LDL transport and formation (unpublished observation from this laboratory).
Even though these general features of how dietary cholesterol and triacylglycerol alter plasma cholesterol levels have been described in the experimental animal and in man, little is known about how these regulatory events are actually articulated within the liver. While LDL receptor activity apparently is controlled by sterol regulatory elements (13) (14) (15) (16) , there is virtually no information on how the nucleus actually senses the cholesterol content of the liver cell. Furthermore, it is not 1 . Abbreviations used in this paper: J, maximal achievable rate of receptor-dependent LDL transport; J., LDL-cholesterol production rate; K.,, the concentration of plasma LDL-cholesterol necessary to achieve half the velocity of Jm; P, the proportionality constant for re-known whether dietary triacylglycerol acts extrahepatically to change net cholesterol balance across the liver, or intrahepatically to alter the relationship between the putative regulatory pool of sterol and the appropriate genes. This situation is further complicated by the fact that the fatty acids ofdietary triacylglycerols may vary markedly in their physical, chemical, and regulatory properties. For example, (a) saturated fatty acids may vary in the length of their hydrocarbon chain; (b) when chain-length is kept constant, the fatty acids may contain varying numbers ofdouble bonds; (c) when chain length and number of double bonds are kept constant, the double bond may exist in either the cis or trans configuration; and (d) fatty acids may occupy different positions on the triacylglycerol molecule, and so possibly be delivered to different tissues during the absorptive process.
In order to begin to understand these complex relationships, the present studies were undertaken to specifically delineate the effect of fatty acid chain length on the regulatory activity of saturated lipids on the parameters of LDL metabolism. Under experimental circumstances, where total dietary cholesterol and triacylglycerol were kept constant, hamsters were fed pure triacylglycerols containing only a single saturated fatty acid that varied in chain length from 6 to 18 carbon atoms. The appearance of each ofthese fatty acids in the liver and extrahepatic tissues was followed, and the effect of the different lipids on cholesterol synthesis in vivo in the major body compartments was quantified. Finally, the plasma LDL-cholesterol concentration, the maximal achievable rate of receptor-dependent transport, and the LDL-cholesterol production rates were measured in each experimental group. These studies demonstrate that only a few of the saturated fatty acids alter parameters of LDL metabolism, and these regulatory effects appear to be articulated within the liver cell itself.
Methods
Animals and diets. Sexually mature male Golden Syrian hamsters -10 wk old (Charles River Breeding Laboratories, Inc., Wilmington, MA) were housed in colony cages for 2 wk before the experiments were started. Animals were subjected to 12 h of light and 12 h of darkness before, and during, the experiments, and measurements were made during the middark phase of the cycle. Four types of diets were employed in these studies (10): (a) plain diet which consisted of ground Wayne Lab Blox (Allied Mills, Chicago, IL) containing 0.02% (wt/wt) cholesterol and 5.0% total lipids; (b) plain diet to which was added 0.12% pure cholesterol dissolved in ethanol and then dried; (c) control diet made from this same ground diet and containing 0.12% added cholesterol and 10% added olive oil; and (d) experimental diets that contained the additions of 0.12% cholesterol, 10% olive oil, and 10% triacylglycerol that was made up ofa single saturated fatty acid varying in chain length from 6:0 to 18:0 (Sigma Chemical Co., St. Louis, MO and Fluka Chemika, A. G., Buchs, Switzerland). In several different experiments, the intake of the diet containing the 10:0 fatty acid was poor, apparently because ofthe pungent odor ofthis particular triacylglycerol. Therefore, the experimental diet for this compound was made up by dissolving the pure triacylglycerol in medium chain triglyceride oil, and then adding this to the control diet. Thus, this particular experimental diet contained 0.12% cholesterol, 10% olive oil, 10% triacylglycerol containing the 10:0 fatty acid, and 7.5% of triacylglycerol containing the 8:0 compound. It should be noted that this additional amount of 8:0 fatty acid is biologically neutral with respect to LDL metabolism. In all studies, groups of animals of essentially identical initial weights were fed these various diets ad lib. for 30 d, at which time a variety of measurements were made.
Dietary lipid absorption. Net lipid absorption was quantified by measuring the amounts of dietary lipid that were eaten, and the amounts that were excreted in the feces. The amount of food consumed by each experimental group of animals was measured over a l-wk interval. During this same week, two 24-h fecal collections were also obtained. Aliquots ofthe diet and feces were dried overnight in an oven and ground, and a total lipid extraction was carried out. After evaporation of the solvent, the amount of lipid in the diet and feces was determined gravimetrically. Net lipid absorption was calculated as the difference between dietary intake and fecal excretion (gram/day per animal).
Tissue fatty acid abundance. Adipose tissue, skeletal muscle, and liver were extracted with Folch reagent, and the samples were methyl esterified (17) . These methyl ester derivatives were then injected into a 30-m long, fused silica capillary column coated with a 0.25-,gm film of Supelcowax 10, and run at 175 to 220'C. The fatty acid abundance in the various major lipid classes was also determined after these classes were first separated on thin layer chromatography plates. The plates used were SIL G-25 (Brinkmann Instrs. Inc., Westbury, NY) and these were developed in hexane/diethyl ether/glacial acetic acid (90:21:2, vol/vol). Samples were extracted from the stationary phase directly into the methanol/benzene phase used for methyl esterification. Tissue cholesterol concentrations. Plasma LDL-cholesterol concentrations were determined by simultaneously centrifuging plasma samples at the densities of 1.020 and 1.063 g/ml (10) . Aliquots of liver were saponified and the total cholesterol content was quantified (10, 18) .
Lipoprotein preparations. Hamster LDL was isolated from donor animals in the density range of 1.020-1.055 g/ml by preparative ultracentrifugation (10, 1 1). The donor animals had been maintained on a low-cholesterol, low-fat diet before harvesting the blood. The LDL was then labeled with either 125I tyramine cellobiose (10, 19) or 131I (10, 20, 21) , and used within 24 h of preparation. All samples were filtered through a 0.45-,gm Millipore filter immediately before injection into recipient animals.
In vivo LDL clearance rates. Rates of tissue LDL clearance were determined in vivo using a primed-continuous infusion of 12'I tyramine cellobiose-labeled LDL (10, 22, 23) . 10 min before termination of the 4-h infusion period, abolus of '3 I-labeled LDLwas administered to each ofthe animals. The animals were then killed at 4 h by exsanguination through the abdominal aorta. The liver was removed and the remaining carcass was frozen in liquid nitrogen and ground to a fine powder. Aliquots were then assayed for radioactivity. Clearance rates were determined by subtracting the tissue space of LDL at 10 min ('3'I dpm per gram of tissue divided by the '3'I dpm per microliter of plasma) from the tissue space ofLDL at 4 h ("25I dpm per gram oftissue divided by the 125I dpm per microliter of plasma). These clearance rates were calculated as the microliter of plasma cleared of its LDL content/ hour per gram of tissue (microliter/hour per gram). In addition, these rates were multiplied by the whole liver and carcass weights in order to calculate LDL clearance by these two whole tissues (microliter/hour per tissue).
In vivo LDL-cholesterol uptake rates. From these LDL clearance rates, uptake rates of LDL cholesterol were determined. These uptake rates were expressed as the absolute mass of LDL cholesterol that was taken up per hour per gram of tissue (microgram/hour per gram) and were calculated by multiplying the clearance rates of LDL (microliter/ hour per gram) by the plasma LDL-cholesterol concentration (microgram/microliter). These rates, in turn, were multiplied by the whole liver and carcass weights to give the LDL-cholesterol uptake rates per whole tissue (microgram/hour per tissue), and these values were then normalized to a constant body weight of 100 g.
In vivo LDL-cholesterol production rates. Because these studies were performed during steady-state conditions where there was no detectable change in the plasma LDL-cholesterol concentration, the sum of the LDL-cholesterol uptake rates in all of the tissues of the animal must equal the rate of LDL-cholesterol production. Thus, LDL-cholesterol production rates were calculated by summing the LDL-choles-terol uptake rates in the liver and carcass, and these values were expressed as the microgram of LDL-cholesterol produced per hour per whole animal (microgram/hour per animal). These rates were then normalized to a constant body weight of 100 g.
In vivo hepatic sterol synthesis. Animals were killed by exsanguination through the abdominal aorta 1 h after the intravenous administration of [3H]water (100 mCi). Liver, small intestine, and the entire remaining carcass were then saponified, and digitonin precipitable sterols were isolated, as previously described (24) (25) (26) . The rates of sterol synthesis in vivo are expressed as the nanomoles of[3H]water incorporated into digitonin precipitable sterols per hour per whole liver, small intestine, carcass, and whole animal (nanomoles/hour per organ or animal).
Calculations. The steady-state concentration of LDL cholesterol is known to be determined by four separate parameters of LDL metabolism (27) . The rate at which LDL cholesterol is taken up by a particular organ or by all of the tissues of the body (Qj) is equal to the sum ofthe rates of uptake by the receptor-dependent (>d) and receptor-independent (QJ) transport processes in that organ or whole animal. Since Jd equals (J'C,)/(Km + Cl) and Ji equals PC,, it follows that Jt for any organ or for the whole animal can be calculated from the following expression (8, 27) :
The parameter 1m is the maximal receptor-dependent transport velocity (a reflection ofreceptor number); Km is the plasma concentration of LDL-cholesterol at which one half of this maximal transport rate is achieved (a reflection of receptor affinity); C, is the concentration of plasma LDL cholesterol in a given animal; and P is the proportionality constant for LDL transport by way of the receptor-independent pathway. The relationship between J, and C, can be defined for a particular organ like the liver or the whole animal. Furthermore, in the latter case, this equation can be rearranged to give an expression that describes how the plasma LDL-cholesterol concentration will change in the whole animal given any alteration in receptor number (7m) or LDLcholesterol production, since, in the steady state, the rate of LDL-cholesterol removal from the plasma space (J.) must equal the rate ofentry into the plasma. This second expression is as follows:
(2) C1~~~~2 P added to the diets to partially suppress hepatic receptor-dependent transport and so make the animals maximally sensitive to the regulatory action of saturated fatty acids (10, 12) .
Thus, on the basis of these preliminary investigations, the control diet contained a constant level of added cholesterol (0.12%) and olive oil (10%), and each experimental diet contained an additional 10% of one ofthe triacylglycerols made up of the fatty acids 6:0 through 18:0. The absorption and growth characteristics of hamsters fed these diets for 30 d are shown in Fig. 1 . The animals fed the control diet absorbed an average of 1.4 g of lipid per day, while those receiving the seven different experimental diets all absorbed 2.5 g of lipid per day (A). At the beginning of the feeding period, the animals had been distributed so that the mean weights of each experimental group were the same. After 30 d of eating each diet, all groups of animals had gained essentially identical amounts ofweight and averaged -150 g (B). Thus, these studies suggested that under the conditions of these experiments the various saturated fatty acids were being well absorbed and utilized by the animals.
To further confirm that the specific fatty acids being fed reached the liver and other tissues, aliquots of several organs were removed from animals fed the eight different diets for 30 d, and the distribution of specific fatty acids in the total lipid extracts of these tissues was determined. Since a large fraction of dietary fatty acids is delivered by the chylomicrons directly to storage sites in the peripheral adipose tissue, the distribution of fatty acids in this tissue was examined first. As shown in Table I , in animals fed the control diet alone the predominant species in adipose tissue lipids were the 18:1 (51.0%), 16 :0 (20.1%), and 18:2 (16.2%) fatty acids. There were no detectable fatty acids of chain length shorter than 12:0. This was also true in the animals fed the experimental diets containing the 6:0, 8:0, and 10:0 fatty acids; furthermore, in these same three groups there was no change in relative abundance ofthe longer chain-length fatty acids. However, when the 12:0, 14:0, 16:0, and 18:0 fatty acids were in the diets, there was a significant increase in the relative abundance of each ofthese lipids in the
The specific values for each of these parameters in the liver and whole animal were determined in a group ofhamsters fed plain diet, and these are presented in Table III . In each experiment, changes in receptor activity (J.) and production rate (J.) are given relative to these absolute values, i.e., they are expressed as a percentage of the respective values found in simultaneously run animals receiving the plain diet.
Where appropriate, mean values± 1 SEM are given. The Student's t test was used (P < 0.05) to compare two treatments (28) .
Results
These studies were specifically undertaken using triacylglycerols that contained only a single saturated fatty acid, rather than mixtures of fatty acids, so that the metabolic and regulatory effects of each compound could be more accurately identified. However, it was anticipated that the triacylglycerols containing the longer chain-length fatty acids would be poorly absorbed, and this proved to be the case in preliminary experiments where significant steatorrhea was identified in animals fed triacylglycerols containing the 16:0 and 18:0 fatty acids. After testing various combinations of diets, however, it was found that this steatorrhea was minimized when the pure triacylglycerols were mixed with an equal weight of olive oil. In addition to these triacylglycerols, a constant level ofcholesterol was also (Fig. 1) , indicated that each of the fatty acids was well absorbed from the experimental diets and reached the target tissues.
To further elucidate where in the hepatic lipids these changes in fatty acid composition occurred, the total lipid extracts were next separated into triacylglycerols, cholesteryl esters, and phospholipids, and the relative abundance ofthe fatty acids in each of these classes was then quantified. As shown in Table II , in the animals fed the control diet the major fatty acids in hepatic triacylglycerols were the 18:1 (34.4%) and 16:0 (28.1%) compounds (A). There were no significant amounts of fatty acids with a chain length of 12 carbon atoms or less. Feeding the 14:0, 16:0, and 18:0 fatty acids increased the mean levels of these respective compounds in this hepatic triacylglycerol fraction, but these differences did not achieve statistical significance. Thus, in general, the abundance of different fatty acids in the triacylglycerols of the liver was relatively insensitive to the abundance of these fatty acids in the diet. This was not true of the cholesteryl ester fraction, however, where the major fatty acid esterified to cholesterol in the control animals was the 18:1 (67.2%) compound. The abundance of the 14:0, 16:0, and 18:0 compounds esterified to cholesterol became significantly elevated after the feeding of these respective fatty acids (B). Furthermore, as found in the total lipid extracts from the liver, the relative abundance ofthe 16:0 fatty acid was increased with the feeding of the 12:0 and 14:0, but not the 18:0, fatty acids, as well as by feeding of the 16:0 compound. Like the triacylglycerol fraction, there was little change in the relative abundance of the fatty acids incorporated into the hepatic phospholipid fraction (C). A small, but significant, increase in the abundance of the 16:0 fatty acid was induced by feeding this compound; otherwise the relative abundance of the different fatty acids remained remarkably constant, regardless of what was fed in the diet. Aliquots of the total lipid extracts from the livers of the animals described in Table I Having established that these various dietary fatty acids reached the peripheral adipose and muscle tissues as well as the liver, the effect of these lipids on the major parameters of LDL metabolism was next investigated. First, however, it was necessary to define the absolute magnitude of maximal receptor-dependent LDL-cholesterol transport (Jm) in the liver, and the LDL-cholesterol production rate (Jt) in animals fed the control diet used in these experiments. As outlined in Table III , in hamsters fed plain ground diet with no lipid additives, .J was low (166 ,ig/h) and Jl was high (653 jg/h), so that the mean was fed this same diet to which was added 0.12% cholesterol, while a third group (control diet) was fed this diet containing 0.12% cholesterol and 10% olive oil. At the end of the feeding period the rates of receptor-dependent and receptor-independent LDL-cholesterol transport into the liver and remaining organs of the body were measured in vivo, and these values were used to calculate the absolute rates of maximal receptordependent transport (JI) in the liver and the LDL-cholesterol production rate in the whole animal (Jt). Both of these rates were then normalized to a constant 100-g body weight, and so are expressed as the ug of LDL-cholesterol transported into the liver and produced by the whole animal per h per 100 g animal. In addition, the concentration of LDL-cholesterol in the plasma (mg/dl) and total cholesterol in the liver (mg/g) of each
animal was also determined. Each value represents the mean± 1 SEM for data from 6 animals. * Value is significantly different (P < 0.05) from the corresponding value found in the animals fed plain diet. (7, 10, 12) . With these absolute values for the parameters of LDL metabolism defined in the animals receiving the control diet, similar measurements were next made in groups of 18 hamsters eating the experimental diets containing the various saturated fatty acids. As shown in Fig. 2 , intake oftriacylglycerol containing the 6:0, 8:0, and 10:0 fatty acids had no significant effect on the plasma LDL-cholesterol concentration (A), hepatic receptor activity (B) or LDL-cholesterol production rate (C) when compared to the control diet. Furthermore, as summarized in Fig. 3 , these fatty acids also did not alter the concentration of cholesterol in the liver. However, when either the 12:0, 14:0, or 16:0 compounds was fed, there was significant suppression of hepatic receptor activity (B), a reciprocal increase in the relative production rate (C), and a near doubling ofthe LDL-cholesterol concentration in the plasma (A). In addition, the heno A10 Table III . Each value represents the mean±l SEM for 18 animals. *Indicates the value is significantly different (P < 0.05) from the corresponding value found in the animals fed the control diet. (Fig. 2) . Thus, these three saturated fatty acids significantly altered the parameters of LDL transport and production, and these changes alone were sufficient to account for the near doubling of the LDL-cholesterol concentration observed in these experiments.
The results obtained when the remaining long-chain saturated fatty acid, the 18:0 compound, was fed, were very different. Even though this fatty acid reduced the level of cholesterol in the liver to the same degree as did the 16:0 compound (Fig.  3) , it did not alter either the relative receptor activity (Fig. 2 B) or production rate (C) and, as a consequence, it had no effect on the plasma LDL-cholesterol level (A). Like the 6:0, 8:0, and 10:0 compounds, the 18:0 fatty acid apparently exerts no metabolic regulation in the liver on the transport parameters that dictate plasma cholesterol levels.
While these results are all consistent with an intrahepatic effect of these fatty acids, one additional experiment was done to rule out the possibility that this regulation was, in fact, mediated through a change in net sterol delivery from the intestine or peripheral organs to the liver. Using animals fed experimental diets containing either the 16:0 or 18:0 fatty acids, rates of cholesterol synthesis were measured in vivo in the small intestine, liver, and remaining organs of the carcass. As shown in Table IV , in animals receiving the control diet, the rate of whole animal sterol synthesis equaled 4,861 nmol/h, and 1.4% ofthis occurred in the liver, 12% in the small intestine, and 87% in the remaining tissues of the body. It should be noted that hepatic sterol synthesis in the liver of animals receiving plain diet equals -300 nmol/h. The lower rate found in this study reflects suppression ofhepatic synthesis by the small amount of cholesterol present in the control diet. When either the 16:0 or 18:0 compound was fed, there was a small, but significant, increase in the rate of hepatic sterol synthesis with both fatty acids, but no differences were found in the rates ofsterol synthe- 
Discussion
The concentration of circulating LDL cholesterol is, for practical purposes, determined by the rate of LDL-cholesterol formation relative to the rate ofreceptor-dependent LDL removal from the plasma (27) . Both of these processes, in turn, are largely dictated by events taking place in the liver. This organ, for example, is the principal location of receptor activity in the body (8, 9, 22, 23, 29) . Furthermore, while LDL itself is probably not secreted by the liver (30) , this organ nevertheless also plays a critical role in determining the LDL-cholesterol production rate. Partially metabolized very low density lipoprotein particles are apparently normally cleared from the plasma by hepatic LDL receptors, and so are not converted to LDL (31) (32) (33) . Thus, there is usually a reciprocal relationship observed between Jm and Jt (e.g., Fig. 2) , regardless of whether receptor activity is altered through genetic or dietary mechanisms (7, 9, 10, 34) . The liver also plays a central role in the metabolism of dietary lipids, including both cholesterol and fatty acids, and it is now apparent that the inflow ofthese lipids leads to complex changes in both Jm and Jt which, in turn, bring about significant alterations in steady-state LDL-cholesterol levels. How these changes are mediated at the cellular level, however, is very poorly understood.
The most dramatic changes in LDL-cholesterol levels are seen when saturated fatty acids are fed in conjunction with cholesterol (11, 35, 36) . In the hamster, for example, the plasma LDL-cholesterol level is elevated over threefold when such triacylglycerols are fed along with small quantities ofcholesterol, as compared to feeding the same quantity of cholesterol alone. These changes result from significant suppression ofJmI coupled with a near doubling ofJt (12) . One ofthe critical questions addressed in the present study is which of the saturated fatty acids is responsible for these changes.
There are known to be significant differences in the manner in which different fatty acids are handled by the body. Those saturated fatty acids of short and medium chain length are fairly hydrophilic, and so are rapidly absorbed across the intestinal brush border without the intervention ofmicellar solubilization (37, 38) . Once absorbed, these compounds are not reesterified and incorporated into the nascent chylomicron but, rather, pass directly into the portal circulation from which they are extracted by the liver. Within the liver, these fatty acids are able to enter the mitochondrial compartment, without using the carnitine transfer process (39) , where they are activated by medium chain and long chain acyl-CoA synthetases and oxidized to acetyl CoA (40) . This pool of acetyl-CoA is then available for the various oxidative and synthetic processes normally carried out by the liver cell. Given this information, it is not surprising that the 6:0, 8:0, and 10:0 fatty acids cannot be detected in the lipids of either the peripheral adipose tissue or liver (Table I) , even after feeding these three triacylglycerols for 30 d. Furthermore, even though these compounds undoubtedly expand the intrahepatic acetyl-CoA pool (41) , there are no significant changes in the relative abundance of any of the longer chain-length fatty acids (Tables I and II) , nor are there any alterations in Jm, Jt, or the plasma LDL-cholesterol level (Fig. 2) . Thus, the delivery of large quantities of two-carbon units to the liver in this form does not alter any parameter of LDL metabolism.
The saturated fatty acids of longer chain length are more hydrophobic and require micellar solubilization within the intestinal lumen for effective absorption (37, 38) . Within the epithelial cell, these compounds are reesterified, and the triacylglycerol is then incorporated into chylomicrons and delivered to peripheral adipose and muscle tissues. A portion of the triacylglycerol is retained within the chylomicron remnants, and is subsequently taken up by the liver. It is also not surprising, therefore, that the pools of fatty acid found in the adipocyte, muscle cell, and hepatocyte become relatively enriched with the 12:0, 14:0, 16:0, or 18:0 compounds when each of these respective acids is fed in the diet for 30 d (Table I) . Furthermore, the liver is known to contain enzyme systems capable of elongating and desaturating these specific fatty acids (42) . This very likely accounts for the observation that the 16:0 fatty acid becomes enriched in this organ after feeding the 12:0 and 14:0, as well as the 16:0, fatty acids. Notably, however, the abundance of the 18:0 compound becomes increased only after feeding the 18:0 fatty acid, and furthermore, the levels of the 18:1 fatty acid are not increased, even after feeding the 18:0 compound for 30 d. Thus, even though the lipids reaching the liver were being constantly removed, through oxidation and secretion of very low density lipoproteins, in the steady state feeding specific fatty acids results in characteristic changes in the abundance of these compounds in the whole organ (Table  I) , and in the major lipid classes of that organ (Table II) .
In the case of the 12:0, 14:0, and 16:0 compounds, the accumulation of these fatty acids is associated with suppression of hepatic receptor activity, reciprocal increases in the mean LDL-cholesterol production rate, and a marked increase in the LDL-cholesterol level in the plasma (Fig. 2) . In contrast, accu-mutation of the 18:0 fatty acid is not associated with any of these changes, even though it becomes enriched in the liver to the same degree as the 16:0 compound (Table I) . Essentially identical results have been reported in man, at least with respect to changes in the plasma LDL-cholesterol level which was elevated 22% after feeding a diet enriched with the 16:0 fatty acid, but not after feeding the 18:0 compound, for 3 wk (43) . Thus, these results appear to explain why commercial saturated oils such as hydrogenated coconut oil and butter fat (rich in the 12:0, 14:0, and 16:0 fatty acids) are so potent in raising the plasma LDL-cholesterol level, while other equally saturated products such as cocoa butter (rich in the 18:0 fatty acid) are much less active in this regard. Such differences have been observed in both animal studies and in investigations in man (7, 44, 45) . Clearly, the general recommendation against use of saturated fatty acids in the diet should apply only to the 12:0, 14:0, and 16:0 compounds, and not to the 18:0 fatty acid or those with chain lengths of 10 or less carbon atoms.
The manner in which these effects of specific fatty acids are articulated in the liver cell is ofconsiderable theoretical importance. In the male hamsters used in these studies, as in other animals and probably man, receptor activity is maximal and the production rate is minimal under conditions where there is no lipid in the diet (Table III) . The effect on the plasma cholesterol concentration of adding triacylglycerol to such diets is clearly dependent upon the simultaneous addition of cholesterol. In the absence ofdietary sterol, for example, 20% hydrogenated coconut oil raises the plasma LDL-cholesterol level by only 16 mg/dl, but this incremental effect increases to 46, 93, and 1 2 mg/dl under circumstances where the level of dietary cholesterol is increased to 0.06, 0.12, and 0.24%, respectively (10) . Thus, one possibility is that the differential effects ofthese longer chain-length saturated fatty acids can be explained in terms of the varying effects of these compounds on net cholesterol balance across the liver. However, the data do not support this possibility. The absolute rates ofcholesterol synthesis were essentially identical in the intestine and other extrahepatic tissues in animals fed the control diet or the diets containing the 16:0 and 18:0 fatty acids (Table IV) . Furthermore, there was no difference in either the rate ofhepatic cholesterol synthesis (Table IV) or the hepatic cholesterol pool (Fig. 3) in the animals fed the 16:0 and 18:0 compounds. Ifthe failure of the 18:0 fatty acid to suppress Jm was due to a reduction in net cholesterol movement across the liver, then, invariably, there would have been a marked decrease in the sterol pool in the liver accompanied by a significant increase in the rate of hepatic cholesterol synthesis. Neither of these events was observed.
A second possibility is that the presence of these saturated fatty acids within the liver alters the quantitative relationships between the putative regulatory pool ofunesterified cholesterol in the cell and the transcriptional factors that interact with the sterol regulatory elements ofthe LDL receptor gene (14) (15) (16) . It is known, for example, that feeding triacylglycerols containing only the 18:1 or 18:2 fatty acids increases the size ofthe cholesteryl ester pool in the liver, and is associated with an increase in receptor activity (unpublished observations from this laboratory), while feeding saturated fatty acids lowers the pool of cholesterol in the liver cell and suppresses J'. These observations would be consistent with the view that those fatty acids that are good substrates for cholesteryl ester formation lower the effective concentration of free cholesterol in the putative regulatory pool of the cell, while those that are not, e.g., the saturated fatty acids, increase this level and so suppress receptor activity. While this scenario may well be true for groups of different fatty acids in general, it cannot explain the difference observed between the 16:0 and 18:0 fatty acids. Both of these compounds became significantly enriched in the cholesteryl ester pool (Table II) and reduced the content of cholesterol in the liver (Fig. 3 ), yet only the 16:0 fatty acid suppressed receptor activity.
There is a third, and clearly speculative, possibility. When the 12:0, 14:0, or 16:0 fatty acids were fed, the sum of the abundances of the 14:0 and 16:0 fatty acids always became elevated to about 25% (Table I) , and all three of these compounds suppressed Jm equally (Fig. 2) . The 14:0 and 16:0 compounds are now known to be involved in the myristoylation and palmitoylation, respectively, of a variety of proteins, both membrane bound and soluble, that are involved in signal transduction, regulation of a variety of metabolic pathways, and, possibly, processes of membrane fusion (46) (47) (48) . It is conceivable, therefore, that enrichment of the hepatic content of the 14:0 and 16:0 compounds may alter receptor-dependent LDL transport only indirectly through some process that does not necessarily involve changes in either the external or internal pools of cellular cholesterol.
Thus, these studies demonstrate that the dietary saturated fatty acids 12:0, 14:0, and 16:0 accumulate in the liver and suppress hepatic LDL receptor activity, enhance the rate of LDL-cholesterol formation, and markedly elevate the plasma LDL-cholesterol level. Future studies will have to more precisely define why these particular compounds, and not the other saturated fatty acids, are able to alter the intracellular regulatory events that dictate membrane receptor-dependent LDL transport in the liver. Nevertheless, these investigations do emphasize that only these three saturated fatty acids have detrimental effects on the plasma LDL-cholesterol level.
